Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28

NCT00204594 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT00204594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00204594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
Lead sponsor
University Hospital Tuebingen
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2005
Completion date
December 31, 2007
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma